Vaccinex, Inc.
Use of semaphorin-4D binding molecules to promote neurogenesis following stroke

Abstract:

Provided herein are methods for promoting neurogenesis in neural tissue of a patient exhibiting at least one symptom of a central nervous system disorder, the method comprising administering to a subject in need thereof an effective amount of an isolated binding molecule which specifically binds to semaphorin-4D (SEMA4D).